Long-Term Neuropsychiatric Developmental Defects after Neonatal Organophosphate Exposure: Mitigation by Synthetic

Michael James Neff1, Doodipala Samba Reddy2

  • 1Department of Neuroscience and Experimental Therapeutics (M.J.N., D.S.R.) and Institute of Pharmacology and Neurotherapeutics (M.J.N., D.S.R.), School of Medicine, Texas A&M University Health Science Center, Bryan, Texas.

Insights

Pediatric organophosphate (OP) pesticide exposure causes long-term neurodevelopmental deficits in rats. Neurosteroid ganaxolone treatment significantly protected against these behavioral and cognitive impairments, suggesting a potential therapy for children.

Area of Science:

  • Neuroscience
  • Toxicology
  • Developmental Biology

Background:

  • Children are highly susceptible to neurotoxic effects of organophosphate (OP) pesticides and nerve agents.
  • OP poisoning in children can lead to acute seizures and long-term neuropsychiatric disabilities and cognitive impairments.
  • Limited chronic rodent models exist for studying pediatric OP exposure's neurodevelopmental consequences and interventions.

Purpose of the Study:

  • To investigate the protective effect of the neurosteroid ganaxolone (GX) against long-term neurodevelopmental impacts of neonatal organophosphate exposure.
  • To establish a pediatric rodent model for studying chronic effects of OP exposure and potential therapeutic interventions.

Main Methods:

  • Neonatal rats (postnatal day 28) were acutely exposed to the organophosphate diisopropyl-fluorophosphate (DFP).
  • Animals were evaluated for cognitive and behavioral deficits at 3 and 10 months post-exposure, with or without ganaxolone (GX) treatment.
  • Neuropathological analysis, including neuronal counts, neuroinflammation markers, and neurogenesis, was performed at 10 months.

Main Results:

  • DFP exposure induced significant long-term deficits in mood, anxiety, depression, aggression, learning, and memory in pediatric rats.
  • DFP-induced neuropathology included neuronal loss, reduced neurogenesis, increased astrogliosis, neuroinflammation, and mossy fiber sprouting.
  • Ganaxolone (GX) treatment significantly ameliorated behavioral and cognitive deficits and protected against neuroinflammation and neurodegeneration.

Conclusions:

  • This pediatric model effectively replicates the neurodevelopmental consequences of OP exposure observed in children.
  • Neurosteroid intervention with ganaxolone (GX) shows significant protective effects against long-term neurobehavioral and neuropathological deficits.
  • This study supports ganaxolone as a potential therapeutic strategy for mitigating the long-term effects of acute OP exposure in children.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
889
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
991
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.7K
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.5K